MicroRNA-30a-3p Inhibits the Progression of Lung Cancer Via the PI3K/AKT by Targeting DNA Methyltransferase 3a

Overview

Journal Onco Targets Ther

Publisher Dove Medical Press

Specialty Oncology

Date 2019 Nov 8

PMID 31695416

Citations 18

Authors

Desheng Wei

Guangmao Yu

Yeping Zhao

Affiliations

Soon will be listed here.

Abstract

Background: MicroRNAs (miRNAs) are small non-coding RNAs, involved in pathological and physiological processes via regulating target genes expression. Abnormally expressed miR-30a-3p has been verified in several tumors, such as liver cancer, esophageal cancer and lung cancer. It was reported that DNA methylation plays a critical role in the tumorigenesis of lung cancer through regulated tumor suppressor genes silencing. Nevertheless, the potential mechanism of miR-30a-3p in restoring abnormal DNA methylation patterns is still unclear in lung cancer. Therefore, because the miR-30a-3p is complementary to the 3'-untranslated regions (3'-UTR) of DNA methyltransferase 3A (DNMT3A), we investigated whether miRNA-30a-3p could target DNMT3a to regulate the progression of lung cancer cell.

Methods: qRT-PCR was used to evaluate miR-30a-3p and DNMT3a mRNA expression levels in A549 lung cancer cells and normal cell line BEAS-2B. MiR-30a-3p expression plasmid was transferred into A549 cells. The target of miR-30a-3p was detected by luciferase reporter assay. Western blot was used to measure related protein expression levels. MTT assay was used to measure the proliferation of cells in each group. The cycle and apoptosis of cells were detected by flow cytometry.

Results: We found down-regulation of miR-30a-3p mRNA expression and up-regulation of DNMT3a mRNA expression in A549 cells. Overexpression of miR-30a-3p downregulates DNMT3a or blocked DNMT3a by interference vector, significantly inhibited the proliferation and G1/S transition in A549 cells via regulating p38 MAPK pathway, and induced the apoptosis in A549 cells via regulating Bcl-2/Bax protein levels. Furthermore, we observed the opposite phenomenon in A549 cells transfected with both miR-30a-3p and DNMT3a vector.

Conclusion: Our data show that miR-30a-3p suppressed the progression of lung cancer via regulating p38 MAPK pathway by targeting DNMT3A in A549 cells, indicating that miR-30a-3p might be a novel potential therapeutic strategy in the treatment of lung cancer.

Citing Articles

The role of microRNAs in hepatocellular carcinoma: Therapeutic targeting of tumor suppressor and oncogenic genes.

Farsi N, Naghipour B, Shahabi P, Safaralizadeh R, Hajiasgharzadeh K, Dastmalchi N Clin Exp Hepatol. 2024; 9(4):307-319.

PMID: 38774201 PMC: 11103798. DOI: 10.5114/ceh.2023.131669.

Tumor-Suppressive and Immunomodulating Activity of miR-30a-3p and miR-30e-3p in HNSCC Cells and Tumoroids.

Conrad O, Burgy M, Foppolo S, Jehl A, Thiery A, Guihard S Int J Mol Sci. 2023; 24(13).

PMID: 37446353 PMC: 10342301. DOI: 10.3390/ijms241311178.

Microarray data analysis to identify miRNA biomarkers and construct the lncRNA-miRNA-mRNA network in lung adenocarcinoma.

Song Y, Kelava L, Zhang L, Kiss I Medicine (Baltimore). 2022; 101(36):e30393.

PMID: 36086747 PMC: 10980501. DOI: 10.1097/MD.0000000000030393.

Long non-coding RNA HCP5 functions as a sponge of miR-29b-3p and promotes cell growth and metastasis in hepatocellular carcinoma through upregulating DNMT3A.

Zhou Y, Li K, Dai T, Wang H, Hua Z, Bian W Aging (Albany NY). 2021; 13(12):16267-16286.

PMID: 34148029 PMC: 8266334. DOI: 10.18632/aging.203155.

MicroRNA-30a-3p acts as a tumor suppressor in MHCC-97H hepatocellular carcinoma cells by targeting COX-2.

Yang X, Sun J, Sun H, Wen B, Zhang M, An H J Cancer. 2021; 12(13):3945-3957.

PMID: 34093801 PMC: 8176251. DOI: 10.7150/jca.52298.

References

Shen Q, Bae H, Eun J, Kim H, Park S, Shin W . MiR-101 functions as a tumor suppressor by directly targeting nemo-like kinase in liver cancer. Cancer Lett. 2013; 344(2):204-11. DOI: 10.1016/j.canlet.2013.10.030. View

Saha K, Adhikary G, Kanade S, Rorke E, Eckert R . p38δ regulates p53 to control p21Cip1 expression in human epidermal keratinocytes. J Biol Chem. 2014; 289(16):11443-11453. PMC: 4036280. DOI: 10.1074/jbc.M113.543165. View

Ling X, Chen Z, Luo H, Liu Z, Liang Y, Chen G . BCL9, a coactivator for Wnt/β-catenin transcription, is targeted by miR-30c and is associated with prostate cancer progression. Oncol Lett. 2016; 11(3):2001-2008. PMC: 4774446. DOI: 10.3892/ol.2016.4161. View

Fan M, Zhong Y, Shen W, Yuan K, Zhao G, Zhang Y . MiR-30 suppresses lung cancer cell 95D epithelial mesenchymal transition and invasion through targeted regulating Snail. Eur Rev Med Pharmacol Sci. 2017; 21(11):2642-2649. View

Qi B, Wang Y, Chen Z, Li X, Qi Y, Yang Y . Down-regulation of miR-30a-3p/5p promotes esophageal squamous cell carcinoma cell proliferation by activating the Wnt signaling pathway. World J Gastroenterol. 2017; 23(45):7965-7977. PMC: 5725291. DOI: 10.3748/wjg.v23.i45.7965. View

Wang F, Wang Q, Zhou Z, Yu S, Pan S, He Z . Plumbagin induces cell cycle arrest and autophagy and suppresses epithelial to mesenchymal transition involving PI3K/Akt/mTOR-mediated pathway in human pancreatic cancer cells. Drug Des Devel Ther. 2015; 9:537-60. PMC: 4304578. DOI: 10.2147/DDDT.S73689. View

Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M . Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006; 9(3):189-98. DOI: 10.1016/j.ccr.2006.01.025. View

Wang Y, Xie Y, Li X, Lin J, Zhang S, Li Z . MiR-876-5p acts as an inhibitor in hepatocellular carcinoma progression by targeting DNMT3A. Pathol Res Pract. 2018; 214(7):1024-1030. DOI: 10.1016/j.prp.2018.04.012. View

Ma Q, Wang J, Wang Y, Hu C, Mu Q, Yu M . High IDH1 expression is associated with a poor prognosis in cytogenetically normal acute myeloid leukemia. Int J Cancer. 2014; 137(5):1058-65. DOI: 10.1002/ijc.29395. View

10.

Cheng C, Wang H, Chang C, Chu H, Chen C, Yu J . MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer. Breast Cancer Res Treat. 2012; 134(3):1081-93. DOI: 10.1007/s10549-012-2034-4. View

11.

Wang W, Lin H, Zhou L, Zhu Q, Gao S, Xie H . MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma. Eur J Surg Oncol. 2013; 40(11):1586-94. DOI: 10.1016/j.ejso.2013.11.008. View

12.

Kawaguchi T, Yan L, Qi Q, Peng X, Gabriel E, Young J . Overexpression of suppressive microRNAs, miR-30a and miR-200c are associated with improved survival of breast cancer patients. Sci Rep. 2017; 7(1):15945. PMC: 5698306. DOI: 10.1038/s41598-017-16112-y. View

13.

Noseda M, Chang L, McLean G, Grim J, Clurman B, Smith L . Notch activation induces endothelial cell cycle arrest and participates in contact inhibition: role of p21Cip1 repression. Mol Cell Biol. 2004; 24(20):8813-22. PMC: 517869. DOI: 10.1128/MCB.24.20.8813-8822.2004. View

14.

Lin R, Hsu H, Chang J, Chen C, Chen J, Wang Y . Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer. Lung Cancer. 2006; 55(2):205-13. DOI: 10.1016/j.lungcan.2006.10.022. View

15.

Klose R, Bird A . Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci. 2006; 31(2):89-97. DOI: 10.1016/j.tibs.2005.12.008. View

16.

Vaux D, Cory S, Adams J . Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 1988; 335(6189):440-2. DOI: 10.1038/335440a0. View

17.

Yan L, Huang X, Shao Q, Huang M, Deng L, Wu Q . MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA. 2008; 14(11):2348-60. PMC: 2578865. DOI: 10.1261/rna.1034808. View

18.

Liu X, Ji Q, Zhang C, Liu X, Liu Y, Liu N . miR-30a acts as a tumor suppressor by double-targeting COX-2 and BCL9 in H. pylori gastric cancer models. Sci Rep. 2017; 7(1):7113. PMC: 5540978. DOI: 10.1038/s41598-017-07193-w. View

19.

Wiemer E . The role of microRNAs in cancer: no small matter. Eur J Cancer. 2007; 43(10):1529-44. DOI: 10.1016/j.ejca.2007.04.002. View

20.

Mathew L, Lee S, Skuli N, Rao S, Keith B, Nathanson K . Restricted expression of miR-30c-2-3p and miR-30a-3p in clear cell renal cell carcinomas enhances HIF2α activity. Cancer Discov. 2013; 4(1):53-60. PMC: 3947282. DOI: 10.1158/2159-8290.CD-13-0291. View